Mitochondria-Targeting Polyamine-Protoporphyrin Conjugates for Photodynamic Therapy

ChemMedChem. 2018 Jan 8;13(1):15-19. doi: 10.1002/cmdc.201700467. Epub 2017 Nov 7.

Abstract

Two polyamine derivatives of protoporphyrin IX (PPIX) were tested as photodynamic therapy (PDT) agents in HT29 colorectal cancer and HEP3B liver cancer cell lines. These compounds exhibit excellent singlet oxygen quantum yields and show strong in vitro PDT efficacy after 660 nm laser irradiation, whereas exogenous PPIX itself exhibits much weaker PDT effects. Confocal microscopy imaging studies reveal that a protoporphyrin derivative with eight amine moieties has excellent water solubility, and localizes mainly in the mitochondria of both HT29 and HEP3B cells, whereas the cellular distribution of a protoporphyrin derivative with four amine moieties is not as specific. This work demonstrates that polyamine moieties on macrocycles can enhance PDT efficacy by targeting mitochondria.

Keywords: mitochondria; photodynamic therapy; polyamines; porphyrins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Survival / drug effects
  • HT29 Cells
  • Humans
  • Lasers
  • Microscopy, Confocal
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Photochemotherapy
  • Photosensitizing Agents / chemistry
  • Photosensitizing Agents / pharmacology*
  • Photosensitizing Agents / therapeutic use
  • Polyamines / chemistry*
  • Protoporphyrins / chemistry*
  • Singlet Oxygen / metabolism
  • Solubility

Substances

  • Photosensitizing Agents
  • Polyamines
  • Protoporphyrins
  • Singlet Oxygen